106 related articles for article (PubMed ID: 225000)
1. Elevated prolactin levels in bronchogenic carcinoma.
Davis S; Proper S; May PB; Ertel NH
Cancer; 1979 Aug; 44(2):676-9. PubMed ID: 225000
[TBL] [Abstract][Full Text] [Related]
2. Circulating hormones in lung cancer.
Behera D; Malik SK; Sharma BR; Dash RJ
Indian J Med Res; 1984 May; 79():636-40. PubMed ID: 6096269
[No Abstract] [Full Text] [Related]
3. Infrequent elevation of plasma ACTH in patients with bronchogenic carcinoma.
Davis S; May PB
Am J Med Sci; 1982; 283(1):2-7. PubMed ID: 6275702
[TBL] [Abstract][Full Text] [Related]
4. Ectopic hormones in lung cancer patients at diagnosis and during therapy.
Gropp C; Havemann K; Scheuer A
Cancer; 1980 Jul; 46(2):347-54. PubMed ID: 6248192
[TBL] [Abstract][Full Text] [Related]
5. Fibrinolysis in human bronchogenic carcinoma.
Peterson HI; Larsson S; Zettergren L
Bibl Anat; 1975; 13():315-6. PubMed ID: 182114
[No Abstract] [Full Text] [Related]
6. Tissue polypeptide antigen in bronchogenic carcinoma.
Zatloukal P; Glagolicová A; Linhart M; Sebes A; Hencl P; Mĕricka O
Neoplasma; 1993; 40(5):301-3. PubMed ID: 8272159
[TBL] [Abstract][Full Text] [Related]
7. Increased serum calcitonin levels in bronchogenic cancer.
Silva OL; Becker KL; Primack A; Doppman JL; Snider RH
Chest; 1976 Apr; 69(4):495-9. PubMed ID: 177250
[TBL] [Abstract][Full Text] [Related]
8. Circulating blood RNA in lung cancer.
Behera D; Mallik SK; Dani HM; Gumbhir K
J Assoc Physicians India; 1986 Aug; 34(8):579-80. PubMed ID: 2432053
[No Abstract] [Full Text] [Related]
9. Dissociation of thyrotropin and prolactin responsiveness to thyrotropin releasing hormone stimulation in L-dopa treated parkinsonian patients.
Rabey JM; Vardi Y; Ravid R; Ayalon D
Horm Res; 1981; 15(2):78-87. PubMed ID: 6799381
[TBL] [Abstract][Full Text] [Related]
10. Blood coagulation and fibrinolysis in patients with carcinoma of the lung.
Brugarolas A; Elias EG; Takita H; Mink IB; Mittelman A; Ambrus JL
J Med; 1973; 4(2):96-105. PubMed ID: 4127138
[No Abstract] [Full Text] [Related]
11. Adrenocorticotropin, calcitonin, and antidiuretic hormone as tumor markers in patients with bronchogenic carcinoma of various histological types.
Winkelmann W; Deuss U; Allolio B; Hummerich W; Kaulen D; Brosch H; Guyot A; Arnold C
Klin Wochenschr; 1984 Nov; 62(21):1018-24. PubMed ID: 6096627
[TBL] [Abstract][Full Text] [Related]
12. Suppression by thyrotropin-releasing hormone (TRH) of human growth hormone release induced by L-dopa.
Maeda K; Kato Y; Chihara K; Ogo S; Iwasaki Y
J Clin Endocrinol Metab; 1975 Aug; 41(2):408-11. PubMed ID: 239963
[TBL] [Abstract][Full Text] [Related]
13. Serum vitamin 'A' in bronchogenic carcinoma.
Jain NC; Gupta AP; Saksena HC
J Assoc Physicians India; 1984 Jun; 32(6):485-6. PubMed ID: 6511722
[No Abstract] [Full Text] [Related]
14. On the presence of immunoreactive growth hormone in a bronchogenic carcinoma.
Cameron DP; Burger HG; DeKretzer DM; Catt KJ; Best JB
Australas Ann Med; 1969 May; 18(2):143-6. PubMed ID: 4893571
[No Abstract] [Full Text] [Related]
15. Serum calcitonin after pentagastrin stimulation in patients with bronchogenic and breast cancer compared to that in patients with medullary thyroid carcinoma.
Samaan NA; Castillo S; Schultz PN; Khalil KG; Johnston DA
J Clin Endocrinol Metab; 1980 Aug; 51(2):237-41. PubMed ID: 6249833
[TBL] [Abstract][Full Text] [Related]
16. Calcitonin as a marker for bronchogenic cancer: a prospective study.
Silva OL; Broder LE; Doppman JL; Snider RH; Moore CF; Cohen MH; Becker KL
Cancer; 1979 Aug; 44(2):680-4. PubMed ID: 476577
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of preoperative carcinoembryonic antigen (CEA) plasma levels in patients with bronchogenic carcinoma.
Concannon JP; Dalbow MH; Hodgson SE; Headings JJ; Markopoulos E; Mitchell J; Cushing WJ; Liebler GA
Cancer; 1978 Sep; 42(3 Suppl):1477-83. PubMed ID: 709518
[No Abstract] [Full Text] [Related]
18. Sedimentation rate, leucocytes, platelet count and haemoglobin in bronchial carcinoma: an epidemiological study.
Gislason T; Nõu E
Eur J Respir Dis; 1985 Feb; 66(2):141-6. PubMed ID: 2982631
[TBL] [Abstract][Full Text] [Related]
19. [Plasma prolactin and GH response after thyrotropin-releasing hormone (TRH), L-DOPA and sulpiride in patients with senile dementia of Alzheimer type].
Fujita M; Toyoda K; Motomura N; Kuroda K; Shimizu T
Rinsho Shinkeigaku; 1985 Jul; 25(7):767-75. PubMed ID: 3935351
[No Abstract] [Full Text] [Related]
20. Clinical utility of hyaluronic acid values in serum and bronchoalveolar lavage fluid as tumor marker for bronchogenic carcinoma.
Hernández Hernández JR; García García JM; Martínez Muñíz MA; Allende Monclus MT; Ruibal Morell A
Int J Biol Markers; 1995; 10(3):149-55. PubMed ID: 8551057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
